Senior Director, Clinical Quality Assurance (CQA)

successful delivery and expression of the CFTR transgene in the lungs of people with cysticfibrosis after aerosol delivery GENERAL... is designed to be a backbone therapy forming the foundation of treatment of blinding retinal vascular diseases by providing multi...

Lugar: USA | 01/09/2026 17:09:54 PM | Salario: S/. No Especificado | Empresa: 4DMolecularTherapeutics

Director, Corporate Counsel

successful delivery and expression of the CFTR transgene in the lungs of people with cysticfibrosis after aerosol delivery GENERAL... is designed to be a backbone therapy forming the foundation of treatment of blinding retinal vascular diseases by providing multi...

Lugar: USA | 26/08/2026 02:08:24 AM | Salario: S/. No Especificado | Empresa: 4DMolecularTherapeutics

Senior Director, IT Compliance & Governance (Contract)

successful delivery and expression of the CFTR transgene in the lungs of people with cysticfibrosis after aerosol delivery GENERAL... is designed to be a backbone therapy forming the foundation of treatment of blinding retinal vascular diseases by providing multi...

Lugar: USA | 18/08/2026 22:08:49 PM | Salario: S/. No Especificado | Empresa: 4DMolecularTherapeutics

Senior Business Systems Architect

successful delivery and expression of the CFTR transgene in the lungs of people with cysticfibrosis after aerosol delivery GENERAL... is designed to be a backbone therapy forming the foundation of treatment of blinding retinal vascular diseases by providing multi...

Lugar: USA | 11/08/2026 17:08:55 PM | Salario: S/. $167000 - 183000 per year | Empresa: 4DMolecularTherapeutics

Vice President, Clinical Development

successful delivery and expression of the CFTR transgene in the lungs of people with cysticfibrosis after aerosol delivery GENERAL... is designed to be a backbone therapy forming the foundation of treatment of blinding retinal vascular diseases by providing multi...

Lugar: USA | 07/08/2026 23:08:52 PM | Salario: S/. No Especificado | Empresa: 4DMolecularTherapeutics